Lao People's Democratic Republic vs North Macedonia: Percentage of bloodstream infection due to methicillin-resistant
Lao People's Democratic Republic
55.9%
in 2022
North Macedonia
53.8%
in 2022
Lao People's Democratic Republic rank
6th
North Macedonia rank
9th
Percentage of bloodstream infection due to methicillin-resistant over time
- Lao People's Democratic Republic
- North Macedonia
How they compare
Lao People's Democratic Republic currently reports 55.9% against 53.8% in North Macedonia, a difference of 2.1%.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was North Macedonia ahead.
Lao People's Democratic Republic ranks 6th and North Macedonia ranks 9th of 50 countries.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 9.0% | 51.0% | 42.0% | North Macedonia |
| 2020s | 45.3% | 78.2% | 32.9% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Lao People's Democratic Republic or North Macedonia?
- Lao People's Democratic Republic, at 55.9% against 53.8% in North Macedonia as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Lao People's Democratic Republic and North Macedonia?
- 2.1%, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and North Macedonia?
- 6 years are reported by both, from 2017 to 2022.
- How do Lao People's Democratic Republic and North Macedonia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Lao People's Democratic Republic ranks 6th and North Macedonia ranks 9th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.